Skip to main content
Clinical Trials/JPRN-UMIN000003201
JPRN-UMIN000003201
Completed
Phase 2

A phase II study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma - chemoradiation therapy for advanced or recurrent gastric adenocarcinoma

Study group of multi-modality therapy for gastric cancer0 sites5 target enrollmentFebruary 17, 2010
Conditionsgastric cancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
gastric cancer
Sponsor
Study group of multi-modality therapy for gastric cancer
Enrollment
5
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This trial was terminated, because sufficient number of patients enrolled.

Registry
who.int
Start Date
February 17, 2010
End Date
August 31, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Study group of multi-modality therapy for gastric cancer

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Tumor localization is not detected by neither CT, endoscopy nor upper GI series 2\) Serious comorbidities 3\) Severe GI obstruction or gastrointestinal bleeding 4\) Current inflammation or acute inflammatory disease 5\) Allergy to cremophor EL 6\) Brain metastasis with symptom 7\) Female with present pregnancy or breast\-feeding, or contemplating pregnancy. 8\) Registered to other clinical trial 9\) Patients judged inappropriate for the study by the physicians

Outcomes

Primary Outcomes

Not specified

Similar Trials